Biomarkers: Diagnostic Indicators for Human Ailments

Dear Colleagues,

Biomarkers, indicators of medical conditions, play a pivotal role in both research and clinical settings. These quantifiable measures, observed externally, offer accurate and reproducible insights into a patient's health state. Their significance spans basic and clinical research, as well as routine clinical practice, and they have become integral even as primary endpoints in clinical trials.

The integration of biomarkers into clinical trials has become so commonplace that their inclusion as primary endpoints is widely accepted. This is particularly valid for well-defined biomarkers that consistently and accurately predict pertinent clinical outcomes across various treatments and populations. Such integration is not only justified but also essential for advancing medical knowledge and improving patient care.

By assembling comprehensive insights and discussions, this Special Issue strives to offer a holistic view of the diverse applications and implications of biomarkers across a spectrum of medical domains. The overarching goal is to enhance understanding among researchers, clinicians, and the medical community at large, thereby fostering the development of innovative diagnostic tools, effective treatment strategies, and improved patient outcomes. Through a multidimensional exploration of current biomarker research, this issue seeks to illuminate the path forward for harnessing the power of biomarkers in shaping the future of medicine.

Dr. Jun Zhang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• biomarkers
• diagnostics
• prognostic
• predictive
• patient care